# Official Journal C 289A/26 N

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 289A |
| | |
| English edition | Information and Notices | Volume 4726 November 2004 |

ISSN 1725-2423

Official Journal

of the European Union

C 289A

English edition

Information and Notices

Volume 4726 November 2004

---

| Notice No | Contents | page |
| --- | --- | --- |
| | III   Notices |
| | European Medicines Agency |
| 2004/C 289A/1 | Recruitment for the European Medicines Agency (London) | 1 |

Notice No

Contents

page

III   Notices

European Medicines Agency

2004/C 289A/1

Recruitment for the European Medicines Agency (London)

1

| EN | |
| --- | --- |

EN

---

III Notices

European Medicines Agency

| 26.11.2004 | EN | Official Journal of the European Union | CA 289/1 |
| --- | --- | --- | --- |

26.11.2004

EN

Official Journal of the European Union

CA 289/1

---

RECRUITMENT FOR THE EUROPEAN MEDICINES AGENCY (LONDON)

(2004/C 289 A/01)

The Agency is responsible for coordinating the evaluation and supervision of medicinal products for human and veterinary use in the European Union (see Council Regulation (EEC) No 2309/93 of 22 July 1993 (
  Official Journal of the European Union L 214 of 24 August 1993) and Council Regulation (EC) No 726/2004 of 31 March 2004 (
  Official Journal of the European Union L 136 of 30 April 2004). The EMEA was established in January 1995. It has many close contacts with the European Commission, 25 EU Member States, EEA countries and many other groups in government and the private sector.

Further information on the EMEA and its activities is readily accessible through the Internet; our web address is http://www.emea.eu.int

The European Medicines Agency is organising selection procedures with a view to drawing up reserve lists for:

| — | EMEA/A/200: Head of Sector, Safety and Efficacy, Unit for the Pre-authorisation Evaluation of Medicines for Human Use (A*9) |
| --- | --- |

—

EMEA/A/200: Head of Sector, Safety and Efficacy, Unit for the Pre-authorisation Evaluation of Medicines for Human Use (A*9)

| — | EMEA/B/201: Assistant, IT Sector (system administrator operations) (B*4) |
| --- | --- |

—

EMEA/B/201: Assistant, IT Sector (system administrator operations) (B*4)

| — | EMEA/A/202: Administrator, EudraVigilance, Unit for the Post-authorisation Evaluation of Medicines for Human Use (A*6) |
| --- | --- |

—

EMEA/A/202: Administrator, EudraVigilance, Unit for the Post-authorisation Evaluation of Medicines for Human Use (A*6)

| — | EMEA/B/203: Assistant, copywriter and editor for printed and web publications, Executive Support Sector B*4) |
| --- | --- |

—

EMEA/B/203: Assistant, copywriter and editor for printed and web publications, Executive Support Sector B*4)

Selected candidates will be included on a reserve list and, depending on the budgetary situation, may be offered a five-year renewable contract in accordance with the Conditions of employment of other servants of the European Communities (
  Official Journal of the European Union L 56 of 4 March 1968)  (1).

The place of employment shall be London.

Candidates must be nationals of a Member State of the European Communities, or of Iceland, Norway or Liechtenstein, on condition that they have full rights as a citizen.

The complete conditions, the job descriptions and the necessary application form should be downloaded from the EMEA website http://www.emea.eu.int. The application form must be duly signed and dated and, together with all documentary evidence, must be returned no later than
  7 January 2005
  (date of postmark) to the following address:
  EMEA — Head of Personnel, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom (Tel: (44-207) 418 84 00; Fax: (44-207) 418 84 16).

---

(1)  The Council has adopted new Staff Regulations which entered into force on 1 May 2004. These Regulations include a new career structure. Successful candidates would therefore be recruited on the basis of the new Staff Regulations, in accordance with the arrangements set out, in particular, in Article 12 of Section 2 of Annex XIII (see the IntraComm website: http://www.europa.eu.int)

---